{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:05:59Z","timestamp":1790892359081,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2003,6,3]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background\u2014<\/jats:italic>\n            <\/jats:bold>\n            Nebivolol and carvedilol are third-generation \u03b2-adrenoreceptor antagonists, which unlike classic \u03b2-blockers, have additional endothelium-dependent vasodilating properties specifically related to microcirculation by a molecular mechanism that still remains unclear. We hypothesized that nebivolol and carvedilol stimulate NO release from microvascular endothelial cells by extracellular ATP, which is a well-established potent autocrine and paracrine signaling factor modulating a variety of cellular functions through the activation of P2-purinoceptors.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Contraction and relaxation of renal glomerular vasculature were measured by determination of intracapillary volume with [\n            <jats:sup>3<\/jats:sup>\n            H]-inulin. Biologically active NO was measured with highly sensitive porphyrinic NO microsensors in a single glomerular endothelial cell (GEC). Extracellular ATP was measured by a luciferin-luciferase assay. Enzymatic degradation of extracellular ATP by apyrase and blockade of P2Y-purinoceptors by suramin or reactive blue 2 inhibited both \u03b2-blocker\u2013induced glomerular vasorelaxations and \u03b2-blocker\u2013stimulated NO release from GECs. Both \u03b2-blocker\u2013induced vasorelaxations were in the micromolar concentration range identical to that required for the \u03b2-blocker stimulation of ATP and NO release from GECs. The maximum of NO release for nebivolol and carvedilol was very similar (188\u00b114 and 226\u00b117, respectively). Blockade of ATP release by a mechanosensitive ion channel blocker, Gd\n            <jats:sup>3+<\/jats:sup>\n            , inhibited the \u03b2-blocker\u2013dependent release of ATP and NO from GECs.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            These results demonstrate for the first time that nebivolol and carvedilol induce relaxation of renal glomerular microvasculature through ATP efflux with consequent stimulation of P2Y-purinoceptor\u2013mediated NO release from GECs.\n          <\/jats:p>","DOI":"10.1161\/01.cir.0000066912.58385.de","type":"journal-article","created":{"date-parts":[[2003,5,13]],"date-time":"2003-05-13T05:38:31Z","timestamp":1052804311000},"page":"2747-2752","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":197,"title":["Third-Generation \u03b2-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux"],"prefix":"10.1161","volume":"107","author":[{"given":"Leszek","family":"Kalinowski","sequence":"first","affiliation":[{"name":"From the Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio (T.M., W.L.D.); and the Departments of Laboratory Medicine (L.K.) and Clinical Chemistry (M.S.K., M.J.), Medical University of Gdansk, and Laboratory of Cellular and Molecular Nephrology (L.K., M.J., M.S.K., L.M., S.A.), Medical Research Center of the Polish Academy of Science, Gdansk, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence W.","family":"Dobrucki","sequence":"additional","affiliation":[{"name":"From the Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio (T.M., W.L.D.); and the Departments of Laboratory Medicine (L.K.) and Clinical Chemistry (M.S.K., M.J.), Medical University of Gdansk, and Laboratory of Cellular and Molecular Nephrology (L.K., M.J., M.S.K., L.M., S.A.), Medical Research Center of the Polish Academy of Science, Gdansk, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslawa","family":"Szczepanska-Konkel","sequence":"additional","affiliation":[{"name":"From the Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio (T.M., W.L.D.); and the Departments of Laboratory Medicine (L.K.) and Clinical Chemistry (M.S.K., M.J.), Medical University of Gdansk, and Laboratory of Cellular and Molecular Nephrology (L.K., M.J., M.S.K., L.M., S.A.), Medical Research Center of the Polish Academy of Science, Gdansk, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Jankowski","sequence":"additional","affiliation":[{"name":"From the Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio (T.M., W.L.D.); and the Departments of Laboratory Medicine (L.K.) and Clinical Chemistry (M.S.K., M.J.), Medical University of Gdansk, and Laboratory of Cellular and Molecular Nephrology (L.K., M.J., M.S.K., L.M., S.A.), Medical Research Center of the Polish Academy of Science, Gdansk, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Martyniec","sequence":"additional","affiliation":[{"name":"From the Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio (T.M., W.L.D.); and the Departments of Laboratory Medicine (L.K.) and Clinical Chemistry (M.S.K., M.J.), Medical University of Gdansk, and Laboratory of Cellular and Molecular Nephrology (L.K., M.J., M.S.K., L.M., S.A.), Medical Research Center of the Polish Academy of Science, Gdansk, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Angielski","sequence":"additional","affiliation":[{"name":"From the Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio (T.M., W.L.D.); and the Departments of Laboratory Medicine (L.K.) and Clinical Chemistry (M.S.K., M.J.), Medical University of Gdansk, and Laboratory of Cellular and Molecular Nephrology (L.K., M.J., M.S.K., L.M., S.A.), Medical Research Center of the Polish Academy of Science, Gdansk, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Malinski","sequence":"additional","affiliation":[{"name":"From the Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio (T.M., W.L.D.); and the Departments of Laboratory Medicine (L.K.) and Clinical Chemistry (M.S.K., M.J.), Medical University of Gdansk, and Laboratory of Cellular and Molecular Nephrology (L.K., M.J., M.S.K., L.M., S.A.), Medical Research Center of the Polish Academy of Science, Gdansk, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"151","volume":"17","year":"1999","journal-title":"J Hypertens"},{"key":"e_1_3_2_2_2","first-page":"S13","volume":"38","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.102.5.546"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200005000-00013"},{"key":"e_1_3_2_5_2","first-page":"879","volume":"298","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200009000-00006"},{"key":"e_1_3_2_7_2","first-page":"698","volume":"292","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.102.6.677"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0920013"},{"key":"e_1_3_2_10_2","first-page":"H243","volume":"261","year":"1991","journal-title":"Am J Physiol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2001.0123m.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/358676a0"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701160"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.242"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.105.8.933"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.39.24348"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.33.1.467"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000020524"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200108000-00004"},{"key":"e_1_3_2_20_2","first-page":"219","volume":"18","year":"1995","journal-title":"Ren Physiol Biochem"},{"key":"e_1_3_2_21_2","first-page":"592","volume":"260","year":"1992","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000066912.58385.DE","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T18:32:51Z","timestamp":1715020371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000066912.58385.DE"}},"subtitle":["A Novel Mechanism for Antihypertensive Action"],"short-title":[],"issued":{"date-parts":[[2003,6,3]]},"references-count":21,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2003,6,3]]}},"alternative-id":["10.1161\/01.CIR.0000066912.58385.DE"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000066912.58385.de","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,3]]},"assertion":[{"value":"2003-05-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}